Breast Cancer Res Treat. 2010 Jun 13.
A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer.
http://www.ncbi.nlm.nih.gov/pubmed/20549339
Wednesday, June 16, 2010
China: Sun Yat-sen University_A biomarket or therapy (MicroRNA-125b) for bladder cancer
Int J Cancer. 2010 Jun 14.
MicroRNA-125b suppresses the development of bladder cancer by Targeting E2F3.
http://www.ncbi.nlm.nih.gov/pubmed/20549700
MicroRNA-125b suppresses the development of bladder cancer by Targeting E2F3.
http://www.ncbi.nlm.nih.gov/pubmed/20549700
China: Disease Control and Prevention of Shenzhen_ATM C. 1066-6T biomarker for breast cancer under scrutinizing
Breast Cancer Res Treat. 2010 Jun 11.
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
http://www.ncbi.nlm.nih.gov:80/pubmed/20544271
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls.
http://www.ncbi.nlm.nih.gov:80/pubmed/20544271
Subscribe to:
Posts (Atom)
alveice Team. Powered by Blogger.